Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 6, 2013 - Issue
Submit an article Journal homepage
68
Views
10
CrossRef citations to date
0
Altmetric
Original Research

ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro

Karin Skoglund1 Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
,
Samuel Boiso Moreno1 Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
,
Maria Baytar1 Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
,
Jan-Ingvar Jönsson2 Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
&
Henrik Gréen1 Department of Medical and Health Sciences, Linköping University, Linköping, Sweden;3 Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, SwedenCorrespondence[email protected]
Pages 63-72 | Published online: 20 Aug 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Henrike Bruckmueller & Ingolf Cascorbi. (2021) ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?. Expert Opinion on Drug Metabolism & Toxicology 17:4, pages 369-396.
Read now

Articles from other publishers (9)

Beata Franczyk, Jacek Rysz & Anna Gluba-Brzózka. (2022) Pharmacogenetics of Drugs Used in the Treatment of Cancers. Genes 13:2, pages 311.
Crossref
Shiyu He, Jialu Bian, Qianhang Shao, Ying Zhang, Xu Hao, Xingxian Luo, Yufei Feng & Lin Huang. (2021) Therapeutic Drug Monitoring and Individualized Medicine of Dasatinib: Focus on Clinical Pharmacokinetics and Pharmacodynamics. Frontiers in Pharmacology 12.
Crossref
Meike Kaehler & Ingolf Cascorbi. (2021) Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia. Frontiers in Pharmacology 12.
Crossref
Kan-Kan QuChen-Ning ZhangLi-Xia DongShu-Shan WangZhong-Dong ZhangLin Zhang. (2020) Association of ABCB1 polymorphisms with lipid homeostasis and liver injury response to atorvastatin in the Chinese population. Canadian Journal of Physiology and Pharmacology 98:1, pages 15-22.
Crossref
Ravindran Ankathil, Husin Azlan, Abu Abdullah Dzarr  & Abdul Aziz Baba. (2018) Pharmacogenetics and the treatment of chronic myeloid leukemia: how relevant clinically? An update. Pharmacogenomics 19:5, pages 475-393.
Crossref
Islem Ben Hassine, Hanene Gharbi, Ismail Soltani, Hind Ben Hadj Othman, Ahlem Farrah, Hassiba Amouri, Mouheb Teber, Hela Ghedira, Yosra Ben Youssef, Ines Safra, Salem Abbes & Samia Menif. (2017) Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia. Cancer Chemotherapy and Pharmacology 80:4, pages 829-839.
Crossref
Daniel T. Barratt, Hannah K. Cox, Andrew Menelaou, David T. Yeung, Deborah L. White, Timothy P. Hughes & Andrew A. Somogyi. (2016) CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients. Clinical Pharmacokinetics 56:8, pages 977-985.
Crossref
Géraldine Dessilly, Nadtha Panin, Laure Elens, Vincent Haufroid & Jean-Baptiste Demoulin. (2016) Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib. Scientific Reports 6:1.
Crossref
Marialuisa Polillo, Sara Galimberti, Claudia Baratè, Mario Petrini, Romano Danesi & Antonello Di Paolo. (2015) Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia. International Journal of Molecular Sciences 16:9, pages 22811-22829.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.